Publications by authors named "Kunyu Yang"

Background: Immune checkpoint inhibitors (ICIs) in combination with antiangiogenic drugs have shown promising outcomes in the third-line and subsequent treatments of patients with microsatellite stable metastatic colorectal cancer (MSS-mCRC). Radiotherapy (RT) may enhance the antitumor effect of immunotherapy. However, the effect of RT exposure on patients receiving ICIs and targeted therapy remains unclear.

View Article and Find Full Text PDF

Correction for 'Relieving immunosuppression during long-term anti-angiogenesis therapy using photodynamic therapy and oxygen delivery' by Qianyuan He , , 2020, , 14788-14800, https://doi.org/10.1039/D0NR02750B.

View Article and Find Full Text PDF

Background: To report long-term results of cervical node-positive (CLN+) nasopharyngeal carcinoma (NPC) patients treated with IMRT with one-step nodal clinical target volume (CTVn) delineation by geometric-anatomic expansion from the nodal gross target volume (GTVn).

Materials: CLN+ NPC treated with the same one-step-CTVn delineation in two Chinese academic centers were pooled for this study. GTVn was prescribed to 70 Gy equivalent, CTVn1 was omitted, CTVn2 was prescribed to 45-55 Gy equivalent and defined as GTVn + 3 mm geometric expansion (5 mm if radiological extranodal extension-positive, rENE+) + elective nodal regions defined by anatomic boundary of cervical nodal levels.

View Article and Find Full Text PDF

The ladybird beetle plays an important role as a predator of various arthropods within Asia's rice ecosystems. While pollen could serve as an alternative diet for this beetle, facilitating mass-rearing, its pollinivory might inadvertently result in attacks on crop pollen. This study aims to explore the role of gut bacteria on pollinivory of .

View Article and Find Full Text PDF
Article Synopsis
  • There is a clinical need to improve the effectiveness and safety of current anti-PD-1/PD-L1 cancer immunotherapy, leading to the study of IBI318, a novel bispecific antibody targeting PD-1 and PD-L1 in patients with advanced tumors.
  • The clinical trial consisted of two phases: Phase Ia focused on dose escalation to find the optimal dosage, while Phase Ib evaluated safety and efficacy in patients with non-small cell lung cancer and nasopharyngeal carcinoma.
  • Results showed that IBI318 had a good safety profile with an objective response rate of 15.5% overall, and higher rates in treatment-naïve patients: 45.5% for NSCLC and 30.0% for
View Article and Find Full Text PDF

Background: One of the main challenges of utilizing spot-scanning proton arc therapy (SPArc) in routine clinics is treatment delivery efficiency. Spot reduction, which relies on spot sparsity optimization (SSO), is crucial for achieving high delivery efficiency in SPArc.

Purpose: This study aims to develop a novel SSO approach based on the alternating directions method of multipliers (ADMM) for SPArc to achieve high treatment delivery efficiency and maintain optimal dosimetric plan quality.

View Article and Find Full Text PDF

Developing widely used respiratory syncytial virus (RSV) vaccines remains a significant challenge, despite the recent authorization of two pre-F vaccines for elderly adults. Previous reports have suggested that even when vaccine-induced immunity generates high titers of potent neutralizing antibodies targeting the pre-F protein, it may not fully inhibit breakthrough of RSV infections. This incomplete inhibition of RSV breakthrough infections can lead to an increased risk of enhanced respiratory disease (ERD) in vaccinated individuals.

View Article and Find Full Text PDF

Vaccine-based therapeutics for cancers face several challenges including lack of immunogenicity and tumor escape pathways for single antigen targets. It has been reported that radiotherapy has an in situ vaccine effect that provides tumor antigens following irradiation, helping to activate antigen-presenting cells (APCs). Herein, a new vaccine approach is developed by combining genetically engineered irradiated tumor cell debris (RTD) and hyaluronic acid (HA), termed HA@RTD.

View Article and Find Full Text PDF
Article Synopsis
  • * It identifies a specific population of Ki67 proliferating regulatory T cells that express immunosuppressive markers, which correlates with treatment outcomes; higher levels were seen in patients who relapsed.
  • * The findings indicate that low baseline levels of these Ki67 Tregs can predict the effectiveness of immunotherapy, and similar results were confirmed in two other trials, suggesting a potential for personalized treatment strategies.
View Article and Find Full Text PDF
Article Synopsis
  • This study explored how the anatomy and dosimetry in patients with locally advanced nasopharyngeal carcinoma change during volumetric modulated arc therapy (VMAT) after induction therapy.
  • The research involved 60 patients, using imaging techniques to analyze changes in tumor volume and organ dosages before and after treatment.
  • Results showed significant reductions in tumor and gland volumes, and identified high initial BMI and lack of objective response to induction therapy as risk factors for dose variations in treatment.
View Article and Find Full Text PDF

Radiotherapy (RT) serves as the primary treatment for solid tumors. Its potential to incite an immune response against tumors both locally and distally profoundly impacts clinical outcomes. However, RT may also promote the accumulation of immunosuppressive cytokines and immunosuppressive cells, greatly impeding the activation of antitumor immune responses and substantially limiting the effectiveness of RT.

View Article and Find Full Text PDF

Human enteroviruses (HEV) can cause a range of diseases from mild to potentially life-threatening. Identification and genotyping of HEV are crucial for disease management. Existing typing methods, however, have inherent limitations.

View Article and Find Full Text PDF

Backgrounds: When comparing the delivery of all beams per fraction (ABPF) to single beam per fraction (SBPF), it is observed that SBPF not only helps meet the FLASH dose threshold but also mitigates the uncertainty with beam switching in the FLASH effect. However, SBPF might lead to a higher biological equivalent dose in 2 Gy (EQD2) for normal tissues.

Purpose: This study aims to develop an EQD2-based integrated optimization framework (EQD2-IOF), encompassing robust dose, delivery efficiency, and beam orientation optimization (BOO) for Bragg peak FLASH plans using the SBPF treatment schedule.

View Article and Find Full Text PDF

Background: Positron emission tomography (PET) has been investigated for its ability to reconstruct proton-induced positron activity distributions in proton therapy. This technique holds potential for range verification in clinical practice. Recently, deep learning-based dose estimation from positron activity distributions shows promise for in vivo proton dose monitoring and guided proton therapy.

View Article and Find Full Text PDF

Background: Intensity-modulated proton therapy (IMPT) optimizes spot intensities and position, providing better conformability. However, the successful application of IMPT is dependent upon addressing the challenges posed by range and setup uncertainties. In order to address the uncertainties in IMPT, robust optimization is essential.

View Article and Find Full Text PDF

Objectives: Neoadjuvant chemoimmunotherapy has shown promising results for resectable, locoregionally advanced (LA) head and neck squamous cell carcinoma (L/A HNSCC). We published the first phase II trial of neoadjuvant camrelizumab combined with chemotherapy in resectable, L/A HNSCC, demonstrating it was safe and feasible with favorable pathological complete response (pCR). Here, we report the final analysis results for neoadjuvant chemoimmunotherapy in L/A HNSCC (minimum 2.

View Article and Find Full Text PDF
Article Synopsis
  • This clinical trial explored the effectiveness of adding sintilimab, a PD-1 inhibitor, to standard chemoradiotherapy for patients with high-risk, locoregionally advanced nasopharyngeal carcinoma.
  • Results showed that the sintilimab group had significantly better event-free survival rates compared to the standard therapy group at a median follow-up of nearly 42 months.
  • The trial also reported that a high percentage of patients experienced grade 3-4 adverse events, indicating a need for monitoring side effects in this treatment approach.
View Article and Find Full Text PDF
Article Synopsis
  • Antibody-drug conjugates, like BL-B01D1, show potential for treating advanced solid tumors by targeting EGFR and HER3, aiming to improve patient outcomes.
  • A phase 1 trial in China tested BL-B01D1's safety and effectiveness, involving a diverse group of patients with advanced cancers who had not responded to standard treatments.
  • The trial consists of two phases: phase 1a focused on determining the maximum tolerated dose and safety, while phase 1b aimed to establish the recommended dose for further studies and evaluate tumor response.
View Article and Find Full Text PDF

To evaluate the feasibility of using a deep learning dose prediction approach to identify patients who could benefit most from proton therapy based on the normal tissue complication probability (NTCP) model.Two 3D UNets were established to predict photon and proton doses. A dataset of 95 patients with localized prostate cancer was randomly partitioned into 55, 10, and 30 for training, validation, and testing, respectively.

View Article and Find Full Text PDF

Radiotherapy (RT) is used for over 50 % of cancer patients and can promote adaptive immunity against tumour antigens. However, the underlying mechanisms remain unclear. Here, we discovered that RT induces the release of irradiated tumour cell-derived microparticles (RT-MPs), which significantly upregulate MHC-I expression on the membranes of non-irradiated cells, enhancing the recognition and killing of these cells by T cells.

View Article and Find Full Text PDF

We proposed a deep learning approach to classify various error types in daily VMAT treatment of head and neck cancer patients based on EPID dosimetry, which could provide additional information to support clinical decisions for adaptive planning. 146 arcs from 42 head and neck patients were analyzed. Anatomical changes and setup errors were simulated in 17,820 EPID images of 99 arcs obtained from 30 patients using in-house software for model training, validation, and testing.

View Article and Find Full Text PDF

Reciprocal interactions between the tumor microenvironment (TME) and cancer cells play important roles in tumorigenesis and progression of glioma. Glioma-associated macrophages (GAMs), either of peripheral origin or representing brain-intrinsic microglia, are the majority population of infiltrating immune cells in glioma. GAMs, usually classified into M1 and M2 phenotypes, have remarkable plasticity and regulate tumor progression through different metabolic pathways.

View Article and Find Full Text PDF

Immunotherapy has revolutionized the treatment of cancer. However, its efficacy remains to be optimized. There are at least two major challenges in effectively eradicating cancer cells by immunotherapy.

View Article and Find Full Text PDF

In this study, we first time sequenced and analyzed the 16S rRNA gene data of predator ladybird beetles and globally distributed invasive pest at different stages, and combined data with bacterial genome sequences in to explored the taxonomic distribution, alpha and beta diversity, differentially abundant bacteria, co-occurrence network, and putative functions of their microbial community. Our finding revealed that Walczuchella, which exhibited a higher abundance in , possessed several genes in essential amino acid biosynthesis and seemed to perform roles in providing nutrients to the host, similar to other obligate symbionts in scale insects. , , and , more abundant in , were predicted to have genes related to hydrocarbon, fatty acids, and chitin degradation, which may assist their hosts in digesting the wax shell covering the scale insects.

View Article and Find Full Text PDF